Proteologics Ltd (Israel) Buy Hold or Sell Recommendation

    Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Proteologics Ltd is 'Not Rated'. Macroaxis provides Proteologics Ltd buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PRTL positions. The advice algorithm takes into account all of Proteologics Ltd available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from PRTL buy-and-hold prospective. See also Your Equity Center.

    Time Horizon

    Risk Tolerance

    Execute Advice

    We are unable to locate Proteologics Ltd Advice at this time.

    If you believe the indicator you are trying to look up is valid please let us know and we will check it out.
    Symbol  PRTL
    Name  Proteologics Ltd
    Country   Israel
    Exchange  Tel Aviv

    Other Suggestions

    Purchased over 20 shares of
    a day ago
    Traded for 117.63
    Purchased over 400 shares of
    a day ago
    Traded for 6.39
    Purchased over 40 shares of
    a day ago
    Traded for 65.83
    Purchased few shares of
    a day ago
    Traded for 183.64
    Purchased a lot of shares of
    a day ago
    Traded for 154.4

    Proteologics Ltd Alerts

    Trading Alerts and Improvement Suggestions

    Proteologics Ltd is not yet fully synchronised with the market data
    Proteologics Ltd has some characteristics of a very speculative penny stock
    Proteologics Ltd has high likelihood to experience some financial distress in the next 2 years
    The company reported revenue of . Net Loss for the year was (1.44M) with profit before overhead, payroll, taxes, and interest of 2M.
    PROTEOLOGICS has accumulated about 8.67M in cash with (775K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
    See also Your Equity Center. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.